A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial

BACKGROUND: Multiple pilot studies, including one in colorectal cancer patients, suggest that creatine, an amino acid derivative, augments muscle, improves strength, and thereby could palliate the cancer anorexia/weight loss syndrome. PATIENTS AND METHODS: In this randomized, double-blind, placebo-c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Oncol
Autors principals: Jatoi, A., Steen, P. D., Atherton, P. J., Moore, D. F., Rowland, K. M., Le-Lindqwister, N. A., Adonizio, C. S., Jaslowski, A. J., Sloan, J., Loprinzi, C.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808669/
https://ncbi.nlm.nih.gov/pubmed/28475678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx232
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars